Latikafusp represents a distinct treatment approach for managing specific tumors, particularly cases involving aberrant ALK proteins. This compound functions as an inhibitor of shortened ALK structures, demonstrating https://jimytfj199056.blog5.net/92546449/latikafusp-a-groundbreaking-treatment-strategy